News
Brexit Impact On Drugs - Rising Shortages in UK Highlight Brexit Challenges
19 Apr 24
Biotech, Government, News, Health Care, Top Stories, Markets, General
Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick
17 Apr 24
Analyst Color, Biotech, Equities, Large Cap, News, Health Care, Reiteration, Analyst Ratings, Trading Ideas, General
Deutsche Bank Upgrades AstraZeneca to Hold
16 Apr 24
News, Upgrades, Analyst Ratings
AstraZeneca's Imfinzi/Chemo Combo Doubles Overall Survival In Biliary Tract Cancer Patients At 3 Years, Data Shows
16 Apr 24
Biotech, Large Cap, News, Health Care, General
AstraZeneca's Imfinzi Plus Chemotherapy Doubled Overall Survival Rate At Three Years For Patients With Advanced Biliary Tract Cancer In TOPAZ-1 Phase 3 Trial
16 Apr 24
Biotech, Large Cap, News, Health Care, General
Novo Nordisk/Eli Lilly's Weight Loss Drugs Does Not Cause Suicidal Behaviors - After FDA, European Medicines Agency Says
12 Apr 24
Biotech, Large Cap, News, Health Care, Top Stories, Movers, General
AstraZeneca Hikes Annual Dividend By 7% Just Before Vote On Its CEO's Pay Package Boost
11 Apr 24
Biotech, Large Cap, News, Dividends, Health Care, Movers, Trading Ideas, General
FDA Approves AstraZeneca's Fasenra (Benralizumab) For Add-on Maintenance Treatment For Patients With Severe Asthma Aged 6 To 11 With An Eosinophilic Phenotype
11 Apr 24
Biotech, Large Cap, News, Health Care, FDA, General
AstraZeneca/Daiichi's Flagship Drug Enhertu Secures Accelerated FDA Approval For Pretreated Cancer Patients With Solid Tumor
8 Apr 24
Biotech, News, FDA
US Manufacturing Hits 18-Month High, China's Growth Could Trigger Deflation And More: Economics Weekly Roundup
7 Apr 24
News, Economics, Markets
New Hope for Aggressive Lung Cancer: AstraZeneca's Imfinzi Shows Promising Results in Phase 3 Trial
5 Apr 24
Biotech, Large Cap, News, Health Care, General
US Labor Market Heats Up In March: Payrolls Grow By 303,000, Highest In 10 Months, Dampen June Rate Cut Hopes (UPDATED)
5 Apr 24
Specialty ETFs, Econ #s, Top Stories, Economics, Federal Reserve, Markets, ETFs
A Closer Look at AstraZeneca's Options Market Dynamics
3 Apr 24
Options, Markets
AstraZeneca CEO Highlights Decade-Long Sales Goal Of $45B Along With Investor Doubts As It Lags In Weight Loss Race
2 Apr 24
Biotech, Large Cap, News, Health Care, General
What's Going On European Pharma Giant AstraZeneca Stock On Wednesday?
27 Mar 24
Biotech, Large Cap, News, Health Care, Movers, Trading Ideas, General
AstraZeneca Announced Earlier, Truqap Plus Faslodex Approved In Japan For Patients With Advanced HR-positive Breast Cancer
27 Mar 24
News
EXCLUSIVE: 2024 Witnesses Increase In Biotech Initial Public Offerings
21 Mar 24
Biotech, Health Care, Events, Exclusives, Interview
After Failed Prostate Cancer Study Merck's Keytruda Combination Therapy Flunks In Late-Stage Lung Cancer Study
21 Mar 24
Biotech, Large Cap, News, Health Care, General
Tagrisso With The Addition Of Chemotherapy Showed Favourable Trend In Overall Survival In EGFR-Mutated Advanced Lung Cancer With Further Follow Up In FLAURA2 Phase III Trial
21 Mar 24
Biotech, News, General
Senator Bernie Sanders Applauds GSK's Move To Cap Inhaler Costs At $35 Per Month
21 Mar 24
Biotech, Large Cap, News, Health Care, General
Press releases
Actinium Pharmaceuticals (ATNM) Leads Biotech Innovation Amid Economic Uncertainty
19 Apr 24
News, Press Releases
Navigating Interest Rate Speculations and M&A Trends with a Spotlight on Actinium Pharmaceuticals (ATNM)
18 Apr 24
News, Press Releases
Actinium Pharmaceuticals (ATNM) Garners Attention with Clinical Successes and Strategic Market Moves Amid Growing Radiopharma Interest
17 Apr 24
News, Press Releases
IMFINZI® (durvalumab) plus chemotherapy doubled overall survival rate at three years for patients with advanced biliary tract cancer in TOPAZ-1 Phase III trial
16 Apr 24
Press Releases
Biotech Innovations Paving the Way in Breast Cancer Fight
11 Apr 24
Small Cap, Opinion, Press Releases
FASENRA approved for treatment of children aged 6 to 11 with severe asthma
11 Apr 24
Press Releases
ENHERTU® Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2 Positive Solid Tumors
5 Apr 24
Press Releases
ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US as first tumor-agnostic HER2-directed therapy for previously treated patients with metastatic HER2-positive solid tumors
5 Apr 24
Press Releases
IMFINZI® (durvalumab) significantly improved overall survival and progression-free survival for patients with limited-stage small cell lung cancer in ADRIATIC Phase III trial
5 Apr 24
Press Releases
Datopotamab deruxtecan Biologics License Application accepted in the US for patients with previously treated metastatic HR-positive, HER2-negative breast cancer
2 Apr 24
Press Releases
Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer
2 Apr 24
Press Releases
VOYDEYA™ approved in the US as add-on therapy to ravulizumab or eculizumab for treatment of extravascular hemolysis in adults with the rare disease PNH
1 Apr 24
Press Releases
Actinium Pharmaceuticals (ATNM) Spearheading the Future of Oncology with Iomab-ACT's Innovative Clinical Trial
27 Mar 24
News, Press Releases
Actinium Pharmaceuticals (ATNM): A Prime Buyout Candidate Amidst a Radiopharma Acquisition Wave
26 Mar 24
News, Press Releases
ULTOMIRIS® (ravulizumab-cwvz) approved in the US for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD)
25 Mar 24
Press Releases
FDA Approves Vertex Pharmaceuticals (NASDAQ:VRTX) VX-407 for Phase I Study in Groundbreaking Move Against Polycystic Kidney Disease"
25 Mar 24
News, Press Releases
Actinium Pharmaceuticals Inc (NYSE:ATNM) Surges on Analyst Upgrade Amidst Radiopharma Sector Momentum
22 Mar 24
News, Press Releases
AstraZeneca to acquire Fusion to accelerate the development of next-generation radioconjugates to treat cancer
19 Mar 24
Press Releases
Actinium Pharmaceuticals (NYSE AMERICAN: ATNM) launches strategic initiative focused on the manufacture of the highly sought after medical isotope Actinium-225 (Ac-225)
14 Mar 24
News, Press Releases
AstraZeneca announces initiation of THARROS – a Phase III clinical trial investigating the potential of BREZTRI to improve cardiopulmonary outcomes in people with COPD
13 Mar 24
Press Releases